These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35571444)

  • 1. Analysis of influencing factors on the plasma concentration of first-line anti-tuberculosis drugs-a single-center retrospective cohort study.
    Zhao G; Chen M; Sun L; Xi N
    Ann Transl Med; 2022 Apr; 10(8):461. PubMed ID: 35571444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations among the plasma concentrations of first-line anti-tuberculosis drugs and the physiological parameters influencing concentrations.
    Cheng L; Luo M; Guo Y; Fan Y; Wang P; Zhou G; Qin S; Weng B; Li P; Liu Z; Liu S
    Front Pharmacol; 2023; 14():1248331. PubMed ID: 37869746
    [No Abstract]   [Full Text] [Related]  

  • 3. Standardization and validation of a novel UPLC-MS/MS method to quantify first line anti-tuberculosis drugs in plasma and dried blood spots.
    Herrera-Pérez IG; Rodríguez-Báez AS; Ortiz-Álvarez A; Velarde-Salcedo R; Arriaga-García FJ; Rodríguez-Pinal CJ; Romano-Moreno S; Milán-Segovia RDC; Medellín-Garibay SE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Aug; 1228():123801. PubMed ID: 37453389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of first-line anti-tuberculosis drugs and one metabolite of isoniazid by liquid chromatography/tandem mass spectrometry in patients with human immunodeficiency virus-tuberculosis coinfection.
    Xing Y; Yin L; Le X; Chen J; Zhang L; Li Y; Lu H; Zhang L
    Heliyon; 2021 Jul; 7(7):e07532. PubMed ID: 34296020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low serum concentrations of anti-tuberculosis drugs and determinants of their serum levels.
    Um SW; Lee SW; Kwon SY; Yoon HI; Park KU; Song J; Lee CT; Lee JH
    Int J Tuberc Lung Dis; 2007 Sep; 11(9):972-8. PubMed ID: 17705974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of food intake on the pharmacokinetics of first-line antituberculosis drugs in Taiwanese tuberculosis patients.
    Lin HC; Yu MC; Liu HJ; Bai KJ
    J Formos Med Assoc; 2014 May; 113(5):291-7. PubMed ID: 24594059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
    Kaneko Y; Nagayama N; Kawabe Y; Shimada M; Suzuki J; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Oshima N; Masuda K; Matsui H; Nagai H; Tamura A; Akagawa S; Toyoda E; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2008 Jan; 83(1):13-9. PubMed ID: 18283910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
    Mukherjee A; Velpandian T; Singla M; Kanhiya K; Kabra SK; Lodha R
    Int J Tuberc Lung Dis; 2016 May; 20(5):666-72. PubMed ID: 27084822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of First-Line Drugs Among Children With Tuberculosis in Rural Tanzania.
    Justine M; Yeconia A; Nicodemu I; Augustino D; Gratz J; Mduma E; Heysell SK; Kivuyo S; Mfinanga S; Peloquin CA; Zagurski T; Kibiki GS; Mmbaga B; Houpt ER; Thomas TA
    J Pediatric Infect Dis Soc; 2020 Feb; 9(1):14-20. PubMed ID: 30395239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus.
    Kumar AK; Chandrasekaran V; Kannan T; Murali AL; Lavanya J; Sudha V; Swaminathan S; Ramachandran G
    Eur J Clin Pharmacol; 2017 Jan; 73(1):65-70. PubMed ID: 27651240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of three antituberculosis drugs in the serum of patients with spinal tuberculosis by capillary electrophoresis.
    Wu X; Che X; Qiu Z; Chao J; Kong Z; Li H
    Anal Methods; 2021 Sep; 13(37):4307-4313. PubMed ID: 34473140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced hepatotoxicity of anti-tuberculosis drugs and their serum levels.
    Jeong I; Park JS; Cho YJ; Yoon HI; Song J; Lee CT; Lee JH
    J Korean Med Sci; 2015 Feb; 30(2):167-72. PubMed ID: 25653488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Food significantly reduces plasma concentrations of first-line anti-tuberculosis drugs.
    Kumar AKH; Chandrasekaran V; Kumar AK; Kawaskar M; Lavanya J; Swaminathan S; Ramachandran G
    Indian J Med Res; 2017 Apr; 145(4):530-535. PubMed ID: 28862186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Levels of Antituberculosis Drugs and Their Effect on Tuberculosis Treatment Outcome.
    Park JS; Lee JY; Lee YJ; Kim SJ; Cho YJ; Yoon HI; Lee CT; Song J; Lee JH
    Antimicrob Agents Chemother; 2016 Jan; 60(1):92-8. PubMed ID: 26459901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid and simultaneous determination of ten anti-tuberculosis drugs in human plasma by UPLC-MS/MS with applications in therapeutic drug monitoring.
    Wang X; Zhang H; Han Y; Huo L; Cao Y; Xu X; Ai L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122246. PubMed ID: 32668377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing drug resistance of Mycobacterium tuberculosis isolates in a medical center in northern Taiwan.
    Su WJ; Feng JY; Huang CC; Perng RP
    J Formos Med Assoc; 2008 Mar; 107(3):259-64. PubMed ID: 18400612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-line antituberculosis drugs disrupt endocrine balance and induce ovarian and uterine oxidative stress in rats.
    Adebayo OA; Adesanoye OA; Abolaji OA; Kehinde AO; Adaramoye OA
    J Basic Clin Physiol Pharmacol; 2018 Mar; 29(2):131-140. PubMed ID: 29116933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.